Clinical trial
The Suppression of Toll Like Receptors by Insulin
NCT01151605 is registered in ClinicalTrials.gov with University at Buffalo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Suppression of Toll Like Receptors by Insulin
- Lead sponsor
- University at Buffalo
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2008
- Completion date
- December 31, 2013
- Enrollment
- 42 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.